论文部分内容阅读
目的:探讨生长抑素在消化系统疾病中的治疗临床效果。方法:选取我院自2010年8月-2013年8月间收治的消化系统疾病(门脉高压食管静脉曲张)患者120例患者作为研究对象,随机将患者分成两组即对照组患者和观察组患者,两组患者均为60例,其中对照组患者采用常规治疗措施,观察组患者采用生长抑素治疗,对比两组患者的治疗效果。结果:观察组患者治疗的总有效率为86.67%,对照组数据为76.67%,两组数据差异具有统计学意义,P<0.05。结论:在消化系统治疗的过程中采用生长抑素效果更好,值得推广使用。
Objective: To investigate the clinical effect of somatostatin in the treatment of digestive diseases. Methods: A total of 120 patients with digestive system diseases (portal esophageal varices) admitted to our hospital from August 2010 to August 2013 were selected as the study subjects. Patients were randomly divided into two groups: control group and observation group Patients, two groups of patients were 60 cases, of which the control group of patients with conventional treatment measures, the observation group patients with somatostatin treatment, compared the two groups of patients with treatment. Results: The total effective rate was 86.67% in the observation group and 76.67% in the control group. The difference between the two groups was statistically significant (P <0.05). Conclusion: Somatostatin is better in the process of digestive system therapy and it is worth promoting.